TNF and ovarian carcinoma: CPE treatment of ovarian cancer cells affects TJ function [75], and treatment with recombinant CPE fused to tumor necrosis factor has cytotoxic effects in ovarian cancer cells, supporting the possible development of CPE as targeted therapy for ovarian cancer [151].